StonvexLoading…
StonvexStonvexStonvexCore line items from ALGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.83M | $2.19M | $2.02M | $1.28M |
Operating Income | $-26.93M | $-87.98M | $-66.17M | $-37.81M |
Net Income | $-23.04M | $-24.19M | $-4.31M | $-15.86M |
EPS (Diluted) | $-2.21 | $-2.45 | $-0.44 | $2.90 |
Total Assets | $64.56M | $88.53M | $109.76M | $134.71M |
Total Liabilities | $32.77M | $34.99M | $37.93M | $32.84M |
Cash & Equivalents | $29.98M | $18.30M | $41.95M | $18.66M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 6.19M | 6.18M | 6.15M | 6.15M |